You can edit almost every page by Creating an account and confirming your email.

Karen Y. Wonders

From EverybodyWiki Bios & Wiki


Karen Y. Wonders
Born (1979-01-10) January 10, 1979 (age 47)
🏳️ NationalityAmerican
💼 Occupation
Exercise physiologist, academic and researcher
👩 Spouse(s)Andrew Wonders (m. 2002)
🏅 AwardsParker E. Enright National Award, National Order of Omega
Fellow, American College of Sports Medicine
WiBN Top 25 Women in Business
Outstanding Service Award, College of Education and Human Sciences (CEHS)

Karen Y. Wonders (born January 10, 1979) is an American exercise physiologist, academic and researcher. She is a Professor of Exercise Physiology and Director of the Sports Science Program at Wright State University,[1] and the Founder and CEO of Maple Tree Cancer Alliance.[2] She also serves on the Board of Directors of Midwest American College of Sports Medicine, and Breast Cancer Task Force of Greater Miami Valley.

In 2011, Wonders founded the non-profit organization Maple Tree Cancer Alliance, which provides individualized exercise programming to patients who battle cancer. She is also best known for her book 40-day devotional, Beauty from Ashes. Wonders has received the Dayton Business Journal’s Forty under 40 award[3] and WiBN Top 25 Women in Business award.[4]

Wonders is a fellow of the American College of Sports Medicine.

Education

Wonders graduated with a B.S. degree in Exercise Science in 2000 and later received her M.S. degree in Exercise and Rehabilitative Science in 2002 from Slippery Rock University. She then studied at Cedarville University and earned a Master’s in Ministry in 2018. She first became interested in Cancer Exercise Rehabilitation in 2003, before earning her Ph.D. in Exercise Physiology with a minor in Statistics and Research at the University of Northern Colorado in 2006.[1]

Career

Wonders joined Wright State University as Assistant Professor in 2006. She was promoted to Associate Professor in 2010 and was appointed as a Full Professor in 2014.[1]

Research

Wonders has worked extensively on the role of exercise in cancer treatment.[5]

Role of exercise in DOX treatment

Wonders published a paper in 2008 discussing the impacts of a single bout of acute endurance exercise in terms of the cardiac dysfunction associated with DOX treatment. She found that the acute exercise bout performed 24 hours prior to the DOX treatment protected against cardiac dysfunction, and this exercise-induced cardioprotection can be explained by a reduction in the generation of reactive oxygen species.[6] Wonders also focused her study on trastuzumab and doxorubicin-related cardiotoxicity and suggested that incorporating exercise in the context of the breast cancer treatment trajectory may eliminate the dosage and duration restrictions of these antineoplastic agents and affect quality of life.[7] Furthermore, she studied the limited usage of an effective chemotherapeutic agent doxorubicin (DOX) in terms of its dose-dependent cardiotoxicity. Results of her study showed that DOX treatment reduced wheel running activity in rats, but this reduced running distance was deemed to be cardioprotective as hearts from WR+DOX rats contained higher levels of the favorable α-MHC isoform as compared to SED+DOX.[8] In 2009, she explored endurance exercise training and determined whether the performance of this training prior to administration of the anticancer drugs DOX and GW2974 would be cardioprotective or not.[9]

Treatment strategies for cancer

In her study regarding the strategies for cancer treatment, Wonders suggested exercise rehabilitation as a lifestyle modification that positively affects the lives of patients with CIPN.[10] She examined the impacts of androgen deprivation therapy treatment in the context of cardiac function using Zoladex and an endurance training regimen.[11] She also proposed the benefits of exercise in terms of treating lung cancer patients.[12]

Cost savings analyses

Wonders’ recent work focuses on cost savings analyses in cancer care. Her work has found that cancer patients who exercise during treatment experience an average reduction in medical bills of $3,000 in the first six months of initiation of the exercise program. These observed reductions are specifically measured with emergency room visits, 30-day readmissions, unplanned patient encounters, and length of hospital stay.[13]

Awards/Honors

  • 2000 - Parker E. Enright National Award, Second place, National Order of Omega
  • 2013 - Fellow, American College of Sports Medicine
  • 2017 - 40 under Forty, Dayton Business Journal
  • 2020 - WiBN Top 25 Women in Business[14]
  • 2021 - Outstanding Service Award, College of Education and Human Sciences (CEHS)

Bibliography

Books

  • Exercise Programming for Cancer Patients (2013) ISBN 9788178955810
  • Pediatric Cancer Survivors (2017) ISBN 9789535132196

Selected Articles

  • Wonders, K. Y., Hydock, D. S., Schneider, C. M., & Hayward, R. (2008). Acute exercise protects against doxorubicin cardiotoxicity. Integrative Cancer Therapies, 7(3), 147-154.
  • Wonders, K. Y., & Reigle, B. S. (2009). Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise. Integrative cancer therapies, 8(1), 17-21.
  • Hydock, D. S., Wonders, K. Y., Schneider, C. M., & Hayward, R. (2009). Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain. Anticancer research, 29(11), 4401-4407.
  • Wonders, K. Y., Hydock, D. S., Greufe, S., Schneider, C. M., & Hayward, R. (2009). Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974. Cancer chemotherapy and pharmacology, 64(6), 1105-1113.
  • Wonders, K.Y., Whisler, G., Loy, H., Holt, B., Bohachek, K., & Wise, R. (2013). Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients. Health psychology research, 1(3).
  • Wonders, K.Y. Wise, R., Ondreka, D., Stout, B. (2018). Supervised, Individualized Exercise Programs Help Mitigate Costs During Cancer Treatment. Journal of Palliative Care & Medicine. 8:4. 1000338.
  • Wonders, K. Y., Wise, R., Ondreka, D., & Gratsch, J. (2019). Cost savings analysis of individualized exercise oncology programs. Integrative cancer therapies, 18, 1534735419839466.
  • Wonders, K.Y., Foggia, N., & Wise, R. (2020). Driving Patient Engagement in Exercise Oncology: A Patient’s Journey Through Maple Tree Cancer Alliance. Journal of Clinical Research and Medicine, 3(2): 1-4.
  • Wonders, K. Y., Stemley, M, Hale, R (2020). A Case Study: Patient Response to 12-week Individualized Exercise Program During Radiation and Chemotherapy Treatment. World Journal of Pharmaceutical and Medical Research,6(8): 303-308.

References

  1. 1.0 1.1 1.2 "Karen Y. Wonders, Ph.D."
  2. "Welcome to Maple Tree Cancer Alliance".
  3. "Dayton's 2017 Forty Under 40} honorees".
  4. "Women In Business Networking (WiBN) Program Announces Top 25 Honorees". 25 September 2020.
  5. Wonders, Karen Y.; Safa, Malek M.; Vannorsdall, Emily Jo; Calvo, Alejandro R. (20 May 2018). "Exercise Through Cancer Care". Journal of Clinical Oncology. 36 (15_suppl): 6605. doi:10.1200/JCO.2018.36.15_suppl.6605.
  6. Wonders, Karen Y.; Hydock, David S.; Schneider, Carole M.; Hayward, Reid (2008). "Acute Exercise Protects Against Doxorubicin Cardiotoxicity". Integrative Cancer Therapies. 7 (3): 147–154. doi:10.1177/1534735408322848. PMID 18815146. Unknown parameter |s2cid= ignored (help)
  7. Wonders, Karen Y.; Reigle, Beverly S. (2009). "Trastuzumab and Doxorubicin-Related Cardiotoxicity and the Cardioprotective Role of Exercise". Integrative Cancer Therapies. 8 (1): 17–21. doi:10.1177/1534735408330717. PMID 19174506. Unknown parameter |s2cid= ignored (help)
  8. Hydock, David S.; Wonders, Karen Y.; Schneider, Carole M.; Hayward, Reid (November 2009). "Voluntary Wheel Running in Rats Receiving Doxorubicin: Effects on Running Activity and Cardiac Myosin Heavy Chain". Anticancer Research. 29 (11): 4401–4407. PMID 20032385.
  9. Wonders, Karen Y.; Hydock, David S.; Greufe, Stephanie; Schneider, Carole M.; Hayward, Reid (2009). "Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974". Cancer Chemotherapy and Pharmacology. 64 (6): 1105–1113. doi:10.1007/s00280-009-0967-z. PMID 19352663. Unknown parameter |s2cid= ignored (help)
  10. Wonders, Karen Y.; Reigle, Beverly S.; Drury, Daniel G. (2010). "Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise". Oncology Reviews. 4 (2): 117–125. doi:10.1007/s12156-010-0044-1. Unknown parameter |s2cid= ignored (help)
  11. Hydock, D. S.; Wonders, K. Y.; Schneider, C. M.; Hayward, R. (2006). "Androgen deprivation therapy and cardiac function: effects of endurance training". Prostate Cancer and Prostatic Diseases. 9 (4): 392–398. doi:10.1038/sj.pcan.4500890. PMID 16786038. Unknown parameter |s2cid= ignored (help)
  12. "The Effects and Efficacy of Exercise in Lung Cancer Patients: An Overview".
  13. Wonders, Karen Y.; Wise, Rob; Ondreka, Danielle; Gratsch, Josh (2019). "Cost Savings Analysis of Individualized Exercise Oncology Programs". Integrative cancer therapies. 18. doi:10.1177/1534735419839466. PMID 30938212. Unknown parameter |s2cid= ignored (help)
  14. "Women In Business Networking (WiBN) Program Announces Top 25 Honorees". 25 September 2020.

External links


This article "Karen Wonders" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Karen Wonders. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.